In 2019, DolCas Biotech launched MoriKol, a highly bioavailable, tripeptide collagen hydrolysate. The ingredient is obtained from Kosher and provides specific amino acid sequences needed for collagen structure.
The “beauty-from-within” ingredient is available to US consumers at a low, clinically supported daily dose of just 1g. MoriKol delivers a minimum of 15% of readily utilizable forms of peptides that are absorbed intact.
According to Shavon Jackson-Michael, ND, Director of Medical Scientific Affairs at DolCas, “No US-marketed fish collagen has quantified collagen actives at this level of specificity. Many commercially available collagen hydrolysates require doses between 2.5-10g/day but offer negligible quantities of bioavailable peptides. Bi- and tripeptides are the smallest absorbable units of collagen, and when provided in a finite amount, give greater potential for restorative functions, including fibroblast recruitment to damaged areas and collagen formation from bioavailable building blocks.”
MoriKol is flavorless, odorless, and temperature stable for use in diverse applications and environments. Unlike the traditional collagen ingredients, the product’s freely absorbable collagen peptides are of low molecular weight. This aspect allows for a low dose, and the capsules are highly absorbable and bioactive.
“Collagen is the most abundant protein type in the human body. Supplemental collagen’s potential whole-body application, including ‘beauty-from-within,’ joint health, sports performance, and cardiovascular and digestive system support is far-reaching,” said Jackson-Michael.
